Pieter Zandberg, Jan Peters, Pierre Demacker, M. Smit, Ernst Reeder, Dirk Meuleman (1998)
Tibolone prevents atherosclerotic lesion formation in cholesterol-fed, ovariectomized rabbits.Arteriosclerosis, thrombosis, and vascular biology, 18 12
J. Pfeilschifter, R. Köditz, M. Pfohl, H. Schatz (2002)
Changes in proinflammatory cytokine activity after menopause.Endocrine reviews, 23 1
P. Sarrel (1990)
Sexuality and MenopauseObstetrics & Gynecology, 75
C. Kaushic, Fan Zhou, A. Murdin, C. Wira (2000)
Effects of Estradiol and Progesterone on Susceptibility and Early Immune Responses to Chlamydia trachomatis Infection in the Female Reproductive TractInfection and Immunity, 68
G. Gorodeski, P. Burfeind, S. Gan, D. Pal, F. Abdul-Karim (1998)
Regulation by retinoids of P2Y2 nucleotide receptor mRNA in human uterine cervical cells.American journal of physiology. Cell physiology, 275 3
The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society The Amount of MUC5B Mucin in Cervical Mucus Peaks at Midcycle*
G. Gorodeski, U. Hopfer, B. Santis, R. Eckert, E. Rorke, W. Utian (1995)
Biphasic regulation of paracellular permeability in human cervical cells by two distinct nucleotide receptors.The American journal of physiology, 268 5 Pt 1
S. Judd, P. Sönksen, C. Fox (1991)
Diabetes: a number of common questions on its management.Nursing standard (Royal College of Nursing (Great Britain) : 1987), 5 33
D. Kellerman (2002)
P2Y(2) receptor agonists: a new class of medication targeted at improved mucociliary clearance.Chest, 121 5 Suppl
B. Yerxa, F. Johnson (1999)
P2Y2 receptors agonists: Structure, activity and therapeutic utilityDrugs of The Future, 24
Tsutomu Fujihara, T. Murakami, H. Fujita, Masatsugu Nakamura, Katsuhiko Nakata (2001)
Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model.Investigative ophthalmology & visual science, 42 1
V. Ralevic, G. Burnstock (1998)
Receptors for purines and pyrimidines.Pharmacological reviews, 50 3
E. Laumann, Anthony Paik, R. Rosen (1999)
Sexual dysfunction in the United States: prevalence and predictors.JAMA, 281 6
G. Gorodeski (2002)
Regulation of transcervical permeability by two distinct P2 purinergic receptor mechanisms.American journal of physiology. Cell physiology, 282 1
C. Cario‐Toumaniantz, G. Loirand, L. Ferrier, P. Pacaud (1998)
Non‐genomic inhibition of human P2X7 purinoceptor by 17β‐oestradiolThe Journal of Physiology, 508
B. Yerxa (2001)
Therapeutic use of nucleotides in respiratory and ophthalmic diseasesDrug Development Research, 52
Irwin Goldstein, Berman (1998)
Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndromes.International journal of impotence research, 10 Suppl 2
T. Fujihara, T. Murakami, H. Fujita, Masatsugu Nakamura, K. Nakata (2000)
P2Y2 AGONIST, INS365: A POTENTIAL DRY EYE THERAPEUTIC AGENT.Cornea, 19
Bachmann (1990)
The impact of vaginal health on sexual functionJ Clin Pract Sexual, Special Issue
Goldstein (1998)
Vasculogenic female sexual dysfunctionInt J Impot Res, 10
K. Carlson (1997)
Outcomes of hysterectomy.Clinical obstetrics and gynecology, 40 4
A. Matejuk, K. Adlard, A. Zamora, M. Silverman, A. Vandenbark, H. Offner (2001)
17β‐estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitisJournal of Neuroscience Research, 65
Notelovitz (1990)
Management of the changing vaginaJ Clin Pract Sexual, 16
E. Key, S. Smith (1991)
Management of vaginal dryness.Nursing standard (Royal College of Nursing (Great Britain) : 1987), 5 31
Gipson (2001)
The amount of MUC5B mucin in cervical mucus peaks at midcycleJ Clin Endocrinol Metab, 86
Fertility and Sterility – Unpaywall
Published: Feb 1, 2003
Access the full text.
Sign up today, get DeepDyve free for 14 days.